Elekta's Agility Radiation Therapy Beam-shaping Innovation for Cancer Treatments Receives U.S. 510(k) Clearance

Elekta's Agility Radiation Therapy Beam- shaping Innovation for Cancer Treatments Receives U.S. 510(k) Clearance PR Newswire ATLANTA, June 22, 2012 - Utilizing new and faster technology, Agility multi-leaf collimator (MLC) expected to further improve therapy for oncology patients, accelerate treatment times ATLANTA, June 22, 2012 /PRNewswire/ -- Using a combination of 160 high- resolution tungsten leaves and dramatically faster leaf movement, Elekta's revolutionary new Agility™* MLC promises a new level of precision and delivery speed in radiation therapy treatments for cancer patients. Elekta recently received 510(k) clearance (K121328) from the U.S. Food and Drug Administration (FDA) for Agility, enabling U.S. medical centers to provide these clinical benefits to their patients with cancer. To view the multimedia assets associated with this release, please visit: http://www.multivu.com/mnr/55638-elekta-agility-radiation-therapy- radiotherapy-cancer-sbrt An MLC, a device made up of numerous, individual tungsten "leaves," is used to shape beams of therapeutic radiation that are delivered from different angles around the patient. Using twice the number of leaves typical of many standard MLC's, Agility precisely sculpts delivered radiation to the unique contours of the tumor, while reducing the risk of exposure to healthy tissue.